Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00489918 Org: User:
Start: 06/30/07 End: 08/31/08 Due: 08/31/09

A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03978403 Org: User:
Start: 05/29/19 End: 06/28/19 Due: 06/28/20

A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03282227 Org: User:
Start: 11/07/17 End: 05/17/19 Due: 05/17/20

Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04969497 Org: User:
Start: 06/24/21 End: 09/02/21 Due: 09/02/22

A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03708744 Org: User:
Start: 11/01/18 End: 11/20/18 Due: 11/20/19

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Phase: N/A Priority: Normal
NCT ID: NCT02478879 Org: User:
Start: 06/30/15 End: 12/31/15 Due: 12/31/16

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

Phase: N/A Priority: Normal
NCT ID: NCT02459938 Org: User:
Start: 01/31/15 End: 10/31/15 Due: 10/31/16

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02745392 Org: User:
Start: 06/30/16 End: 01/31/17 Due: 01/31/18

Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches

Phase: N/A Priority: Normal
NCT ID: NCT04066023 Org: User:
Start: 10/03/19 End: 04/14/21 Due: 04/14/22